Regen BioPharma, Inc. to Present at the Emerging Growth Conference on March 3, 2023

Rhea-AI Summary

Regen BioPharma, Inc. is set to present at the Emerging Growth Conference on March 8, 2023, providing a platform for interactive engagement between the company and investors. The conference will be held from 1:10 PM to 1:20 PM Eastern time. CEO Dr. David Koos will discuss the company's recent reverse stock split, future financing, and programmatic plans. Investors can register for the event to submit questions live. An archived webcast will also be available for those who cannot attend. Regen BioPharma focuses on developing innovative therapies for cancer and autoimmune disorders, emphasizing a robust pre-clinical pipeline.

Regen BioPharma, Inc. invites individual and institutional investors as well as advisors and analysts to attend its real-time interactive presentation at the Emerging Growth Conference.

SAN DIEGO, March 7, 2023 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBPD) (OTC PINK: RGBAD) (a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs)  will be presenting at the Emerging Growth Conference on March 8, 2023 (https://emerginggrowth.com/conference/).

This live interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company's CEO, Dr. David Koos, in real time.  Please ask your questions during the event and Dr. Koos and his team will do their best to address  as many of your questions as possible.

"We plan to use this time to update our stakeholders on our recent reverse stock split, our future financing and programmatic plans and also to answer shareholder questions," says Dr. David Koos, CEO and Chairman of the Company. 

Regen BioPharma, Inc. will be presenting 1:10 - 1:20 Eastern time on Wednesday March 8, 2023.  Please register here to ensure you are able to attend the conference and receive any updates that are released https://goto.webcasts.com/starthere.jsp?ei=1595542&tp_key=9ac5970e97&sti=rgbp.

If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available on EmergingGrowth.com.

About the Emerging Growth Conference

The Emerging Growth conference is an effective way for public companies to present and communicate their new products, services and other major announcements to the investment community from the convenience of their office, in a time efficient manner.

The Conference focus and coverage includes companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long term growth. Its audience includes potentially tens of thousands of individual and institutional investors, as well as investment advisors and analysts.

About Regen BioPharma Inc.: 

Regen BioPharma, Inc. is a publicly traded biotechnology company (PINK: RGBP) and (PINK: RGBPP). The Company is focused on the immunology and immunotherapy space. The Company is focused on rapidly advancing novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Company is focused on mRNA and small molecule therapies for treating cancer and autoimmune disorders. Additional information on Regen BioPharma is available at http://www.regenbiopharmainc.com.

Disclaimer: This news announcement may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.

CONTACT INFORMATION:

Regen BioPharma Inc.
David R. Koos, Ph.D.
Chairman & Chief Executive Officer
+1-619-722-5505 Phone
+1-619-330-2328 Fax
Email: david.koos@regenbiopharmainc.com

Follow us on Twitter for future updates: https://twitter.com/TheRegenBio

View original content:https://www.prnewswire.com/news-releases/regen-biopharma-inc-to-present-at-the-emerging-growth-conference-on-march-3-2023-301765089.html

SOURCE Regen BioPharma Inc.

FAQ

When is Regen BioPharma presenting at the Emerging Growth Conference?

Regen BioPharma is presenting at the Emerging Growth Conference on March 8, 2023.

What time will Regen BioPharma's presentation occur?

Regen BioPharma's presentation will take place from 1:10 PM to 1:20 PM Eastern time.

Who will be presenting for Regen BioPharma?

CEO Dr. David Koos will be presenting for Regen BioPharma.

What topics will be covered in Regen BioPharma's presentation?

The presentation will cover recent developments, including a reverse stock split, future financing, and programmatic plans.

How can I attend Regen BioPharma's conference presentation?

You can register to attend Regen BioPharma's presentation through the Emerging Growth Conference website.

Will there be a recording available for the Regen BioPharma presentation?

Yes, an archived webcast of Regen BioPharma's presentation will be available after the event.

What is Regen BioPharma's stock symbol?

Regen BioPharma's stock symbols are RGBPD and RGBAD.